Autophagy as a main driver on Smith-Lemli-Opitz syndrome
Autor(a) principal: | |
---|---|
Data de Publicação: | 2018 |
Tipo de documento: | Artigo de conferência |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10400.18/5729 |
Resumo: | Introduction: Cholesterol is an important structural component of cellular membranes and myelin and it was found to play an essential role on embryogenesis and development. In the past most of the scientific investigations concerning this lipid were focused on the consequences of high levels of cholesterol and only a few studies reported the dramatic consequences of low cholesterol levels for cells. In the present investigation we used fibroblasts from Smith-Lemli-Opitz syndrome patients (SLOS) - a metabolic genetic disease affecting the cholesterol biosynthesis pathway - to investigate the consequences of cholesterol deficiency on cell morphology and protein expression. Materials and methods: Morphological studies (MTT test, immunocytochemistry for LC3, MDC and acridine orange coloration as well as electron microscopy) and proteomic analysis (iTRAQ LC /MS-MS) were performed on fibroblasts from SLOS patients and human controls, simultaneously cultivated both on standard conditions and cholesterol depleted media. Results: Morphological studies showed that when endogenous synthesis of cholesterol is inadequate (SLOS) and there is no appropriate supply to overcome cellular needs (cholesterol depleted media), cell proliferation in vitro becomes impaired and autophagy is activated. Once, activation of autophagy, in the absence of cholesterol seems to be a self-rescue mechanism of the cell, we further investigated if there was also changes in protein expression which support surviving cell adaptive modifications. SLOS cells in cholesterol depleted medium show an overexpression of a set of proteins. Mainly, these cells seems to increase MnSOD expression to combat oxidative stress derived from the increased amount of 7-dehydrocholesterol and its derivatives, caused by the inherited enzymatic deficiency and thus control cell proliferation, whereas heat shock 70 kDa protein 4, an autophagic protein (Atg2) also presents a cytoprotective activity and inhibits apoptosis. Conclusion: We conclude that the mechanism by which SLOS fibroblasts handles their metabolic deficit, involves autophagy which plays an important role in cell survival. Furthermore this work provided powerful indications that may be useful to expand the knowledge about the mechanisms involved in cellular pathophysiology of SLOS. |
id |
RCAP_138fea3b8f971a3ccb24ae7940bcdd23 |
---|---|
oai_identifier_str |
oai:repositorio.insa.pt:10400.18/5729 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Autophagy as a main driver on Smith-Lemli-Opitz syndrome7-dehydrocholesterol Reductase DeficiencySmith-Lemli-Opitz SyndromeAutophagyCholesterol DeficiencyInborn Errors of Cholesterol BiosynthesisiTRAQHSPA4CaMKIIMnSODDoenças Cardio e Cérebro-vascularesIntroduction: Cholesterol is an important structural component of cellular membranes and myelin and it was found to play an essential role on embryogenesis and development. In the past most of the scientific investigations concerning this lipid were focused on the consequences of high levels of cholesterol and only a few studies reported the dramatic consequences of low cholesterol levels for cells. In the present investigation we used fibroblasts from Smith-Lemli-Opitz syndrome patients (SLOS) - a metabolic genetic disease affecting the cholesterol biosynthesis pathway - to investigate the consequences of cholesterol deficiency on cell morphology and protein expression. Materials and methods: Morphological studies (MTT test, immunocytochemistry for LC3, MDC and acridine orange coloration as well as electron microscopy) and proteomic analysis (iTRAQ LC /MS-MS) were performed on fibroblasts from SLOS patients and human controls, simultaneously cultivated both on standard conditions and cholesterol depleted media. Results: Morphological studies showed that when endogenous synthesis of cholesterol is inadequate (SLOS) and there is no appropriate supply to overcome cellular needs (cholesterol depleted media), cell proliferation in vitro becomes impaired and autophagy is activated. Once, activation of autophagy, in the absence of cholesterol seems to be a self-rescue mechanism of the cell, we further investigated if there was also changes in protein expression which support surviving cell adaptive modifications. SLOS cells in cholesterol depleted medium show an overexpression of a set of proteins. Mainly, these cells seems to increase MnSOD expression to combat oxidative stress derived from the increased amount of 7-dehydrocholesterol and its derivatives, caused by the inherited enzymatic deficiency and thus control cell proliferation, whereas heat shock 70 kDa protein 4, an autophagic protein (Atg2) also presents a cytoprotective activity and inhibits apoptosis. Conclusion: We conclude that the mechanism by which SLOS fibroblasts handles their metabolic deficit, involves autophagy which plays an important role in cell survival. Furthermore this work provided powerful indications that may be useful to expand the knowledge about the mechanisms involved in cellular pathophysiology of SLOS.Instituto Nacional de Saúde Doutor Ricardo Jorge, IPRepositório Científico do Instituto Nacional de SaúdeCardoso, Maria Luís2019-02-08T10:43:39Z2018-05-252018-05-25T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/conferenceObjectapplication/pdfhttp://hdl.handle.net/10400.18/5729enginfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-07-20T15:40:56Zoai:repositorio.insa.pt:10400.18/5729Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T18:40:14.361837Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Autophagy as a main driver on Smith-Lemli-Opitz syndrome |
title |
Autophagy as a main driver on Smith-Lemli-Opitz syndrome |
spellingShingle |
Autophagy as a main driver on Smith-Lemli-Opitz syndrome Cardoso, Maria Luís 7-dehydrocholesterol Reductase Deficiency Smith-Lemli-Opitz Syndrome Autophagy Cholesterol Deficiency Inborn Errors of Cholesterol Biosynthesis iTRAQ HSPA4 CaMKII MnSOD Doenças Cardio e Cérebro-vasculares |
title_short |
Autophagy as a main driver on Smith-Lemli-Opitz syndrome |
title_full |
Autophagy as a main driver on Smith-Lemli-Opitz syndrome |
title_fullStr |
Autophagy as a main driver on Smith-Lemli-Opitz syndrome |
title_full_unstemmed |
Autophagy as a main driver on Smith-Lemli-Opitz syndrome |
title_sort |
Autophagy as a main driver on Smith-Lemli-Opitz syndrome |
author |
Cardoso, Maria Luís |
author_facet |
Cardoso, Maria Luís |
author_role |
author |
dc.contributor.none.fl_str_mv |
Repositório Científico do Instituto Nacional de Saúde |
dc.contributor.author.fl_str_mv |
Cardoso, Maria Luís |
dc.subject.por.fl_str_mv |
7-dehydrocholesterol Reductase Deficiency Smith-Lemli-Opitz Syndrome Autophagy Cholesterol Deficiency Inborn Errors of Cholesterol Biosynthesis iTRAQ HSPA4 CaMKII MnSOD Doenças Cardio e Cérebro-vasculares |
topic |
7-dehydrocholesterol Reductase Deficiency Smith-Lemli-Opitz Syndrome Autophagy Cholesterol Deficiency Inborn Errors of Cholesterol Biosynthesis iTRAQ HSPA4 CaMKII MnSOD Doenças Cardio e Cérebro-vasculares |
description |
Introduction: Cholesterol is an important structural component of cellular membranes and myelin and it was found to play an essential role on embryogenesis and development. In the past most of the scientific investigations concerning this lipid were focused on the consequences of high levels of cholesterol and only a few studies reported the dramatic consequences of low cholesterol levels for cells. In the present investigation we used fibroblasts from Smith-Lemli-Opitz syndrome patients (SLOS) - a metabolic genetic disease affecting the cholesterol biosynthesis pathway - to investigate the consequences of cholesterol deficiency on cell morphology and protein expression. Materials and methods: Morphological studies (MTT test, immunocytochemistry for LC3, MDC and acridine orange coloration as well as electron microscopy) and proteomic analysis (iTRAQ LC /MS-MS) were performed on fibroblasts from SLOS patients and human controls, simultaneously cultivated both on standard conditions and cholesterol depleted media. Results: Morphological studies showed that when endogenous synthesis of cholesterol is inadequate (SLOS) and there is no appropriate supply to overcome cellular needs (cholesterol depleted media), cell proliferation in vitro becomes impaired and autophagy is activated. Once, activation of autophagy, in the absence of cholesterol seems to be a self-rescue mechanism of the cell, we further investigated if there was also changes in protein expression which support surviving cell adaptive modifications. SLOS cells in cholesterol depleted medium show an overexpression of a set of proteins. Mainly, these cells seems to increase MnSOD expression to combat oxidative stress derived from the increased amount of 7-dehydrocholesterol and its derivatives, caused by the inherited enzymatic deficiency and thus control cell proliferation, whereas heat shock 70 kDa protein 4, an autophagic protein (Atg2) also presents a cytoprotective activity and inhibits apoptosis. Conclusion: We conclude that the mechanism by which SLOS fibroblasts handles their metabolic deficit, involves autophagy which plays an important role in cell survival. Furthermore this work provided powerful indications that may be useful to expand the knowledge about the mechanisms involved in cellular pathophysiology of SLOS. |
publishDate |
2018 |
dc.date.none.fl_str_mv |
2018-05-25 2018-05-25T00:00:00Z 2019-02-08T10:43:39Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/conferenceObject |
format |
conferenceObject |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10400.18/5729 |
url |
http://hdl.handle.net/10400.18/5729 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Instituto Nacional de Saúde Doutor Ricardo Jorge, IP |
publisher.none.fl_str_mv |
Instituto Nacional de Saúde Doutor Ricardo Jorge, IP |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799132144427073537 |